View Future GrowthMedix 過去の業績過去 基準チェック /16Medixは、平均年間6.2%の収益成長を遂げていますが、 Media業界の収益は、年間 成長しています。収益は、平均年間7.1% 0.5%収益成長率で 減少しています。 Medixの自己資本利益率は12.2%であり、純利益率は10.2%です。主要情報6.17%収益成長率5.29%EPS成長率Media 業界の成長9.30%収益成長率-0.48%株主資本利益率12.18%ネット・マージン10.24%前回の決算情報31 Mar 2026最近の業績更新Reported Earnings • May 19Full year 2026 earnings released: EPS: JP¥56.04 (vs JP¥106 in FY 2025)Full year 2026 results: EPS: JP¥56.04 (down from JP¥106 in FY 2025). Revenue: JP¥4.26b (up 2.3% from FY 2025). Net income: JP¥436.0m (down 46% from FY 2025). Profit margin: 10% (down from 19% in FY 2025). The decrease in margin was driven by higher expenses.Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: JP¥19.50 (vs JP¥27.25 in 3Q 2025)Third quarter 2026 results: EPS: JP¥19.50 (down from JP¥27.25 in 3Q 2025). Revenue: JP¥1.06b (down 8.8% from 3Q 2025). Net income: JP¥147.0m (down 29% from 3Q 2025). Profit margin: 14% (down from 18% in 3Q 2025). The decrease in margin was driven by lower revenue.お知らせ • Nov 29Medix Inc. to Report Q3, 2026 Results on Feb 10, 2026Medix Inc. announced that they will report Q3, 2026 results on Feb 10, 2026お知らせ • Sep 04Medix Inc. to Report Q2, 2026 Results on Nov 11, 2025Medix Inc. announced that they will report Q2, 2026 results on Nov 11, 2025お知らせ • May 31Medix Inc. to Report Q1, 2026 Results on Aug 12, 2025Medix Inc. announced that they will report Q1, 2026 results on Aug 12, 2025お知らせ • Mar 22Medix Inc. to Report Fiscal Year 2025 Results on May 13, 2025Medix Inc. announced that they will report fiscal year 2025 results on May 13, 2025すべての更新を表示Recent updatesReported Earnings • May 19Full year 2026 earnings released: EPS: JP¥56.04 (vs JP¥106 in FY 2025)Full year 2026 results: EPS: JP¥56.04 (down from JP¥106 in FY 2025). Revenue: JP¥4.26b (up 2.3% from FY 2025). Net income: JP¥436.0m (down 46% from FY 2025). Profit margin: 10% (down from 19% in FY 2025). The decrease in margin was driven by higher expenses.お知らせ • May 14Medix Inc., Annual General Meeting, Jun 26, 2026Medix Inc., Annual General Meeting, Jun 26, 2026.Upcoming Dividend • Mar 23Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 12 June 2026. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.0%).分析記事 • Feb 16Why Investors Shouldn't Be Surprised By Medix Inc.'s (TSE:331A) Low P/EWith a price-to-earnings (or "P/E") ratio of 7.6x Medix Inc. ( TSE:331A ) may be sending bullish signals at the moment...Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: JP¥19.50 (vs JP¥27.25 in 3Q 2025)Third quarter 2026 results: EPS: JP¥19.50 (down from JP¥27.25 in 3Q 2025). Revenue: JP¥1.06b (down 8.8% from 3Q 2025). Net income: JP¥147.0m (down 29% from 3Q 2025). Profit margin: 14% (down from 18% in 3Q 2025). The decrease in margin was driven by lower revenue.お知らせ • Nov 29Medix Inc. to Report Q3, 2026 Results on Feb 10, 2026Medix Inc. announced that they will report Q3, 2026 results on Feb 10, 2026お知らせ • Sep 16Medix Inc. (TSE:331A) announces an Equity Buyback for 600,000 shares, representing 7.47% for ¥308.4 million.Medix Inc. (TSE:331A) announces a share repurchase program. Under the program, the company will repurchase up to 600,000 shares, representing 7.47% of its issued share capital (excluding treasury stock), for a total purchase price of ¥308.4 million. The shares will be repurchased at a price of ¥514 per share. The purpose of the program is to enable flexible capital policies that respond to changes in the business environment. As of September 16, 2025, the company had 8,030,000 issued shares (excluding treasury stock) and 50,000 treasury shares.お知らせ • Sep 05Medix Inc. (TSE:331A) agreed to acquire 76.91% stake in Star To Asia Co., Ltd from Findstar Co., Ltd., Teppei Fujiwara and Masao Liang for TWD 185 million.Medix Inc. (TSE:331A) agreed to acquire 76.91% stake in Star To Asia Co., Ltd from Findstar Co., Ltd., Teppei Fujiwara and Masao Liang for TWD 185 million on September 4, 2025. A cash consideration of TWD 144 million will be paid by Medix Inc. Medix Inc. will pay an earnout payment of TWD 41 million cash. As part of consideration, TWD 185 million is paid towards common equity of Star To Asia Co., Ltd. The transaction is subject to consummation of due diligence investigation. The expected completion of the transaction is September 30, 2025. The advisory fees is TWD 0.62 million.お知らせ • Sep 04Medix Inc. to Report Q2, 2026 Results on Nov 11, 2025Medix Inc. announced that they will report Q2, 2026 results on Nov 11, 2025お知らせ • May 31Medix Inc. to Report Q1, 2026 Results on Aug 12, 2025Medix Inc. announced that they will report Q1, 2026 results on Aug 12, 2025お知らせ • May 13Medix Inc., Annual General Meeting, Jun 27, 2025Medix Inc., Annual General Meeting, Jun 27, 2025.お知らせ • Mar 22Medix Inc. to Report Fiscal Year 2025 Results on May 13, 2025Medix Inc. announced that they will report fiscal year 2025 results on May 13, 2025お知らせ • Mar 19Medix Inc. has completed an IPO in the amount of ¥1.84 billion.Medix Inc. has completed an IPO in the amount of ¥1.84 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 1,800,000 Price\Range: ¥800 Discount Per Security: ¥64 Security Name: Common Stock Security Type: Common Stock Securities Offered: 500,000 Price\Range: ¥800 Discount Per Security: ¥64収支内訳Medix の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史TSE:331A 収益、費用、利益 ( )JPY Millions日付収益収益G+A経費研究開発費31 Mar 264,2564363,042031 Dec 254,1635172,905030 Sep 254,1545312,893030 Jun 254,1506392,902031 Mar 254,1618032,878031 Mar 244,1794892,936031 Mar 234,2734012,9070質の高い収益: 331Aは 高品質の収益 を持っています。利益率の向上: 331Aの現在の純利益率 (10.2%)は、昨年(19.3%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 331Aの過去 5 年間の前年比収益成長率がプラスであったかどうかを判断するにはデータが不十分です。成長の加速: 331Aは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: 331Aは過去 1 年間で収益成長率がマイナス ( -45.7% ) となったため、 Media業界平均 ( 28.7% ) と比較することが困難です。株主資本利益率高いROE: 331Aの 自己資本利益率 ( 12.2% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMedia 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 14:25終値2026/05/22 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Medix Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • May 19Full year 2026 earnings released: EPS: JP¥56.04 (vs JP¥106 in FY 2025)Full year 2026 results: EPS: JP¥56.04 (down from JP¥106 in FY 2025). Revenue: JP¥4.26b (up 2.3% from FY 2025). Net income: JP¥436.0m (down 46% from FY 2025). Profit margin: 10% (down from 19% in FY 2025). The decrease in margin was driven by higher expenses.
Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: JP¥19.50 (vs JP¥27.25 in 3Q 2025)Third quarter 2026 results: EPS: JP¥19.50 (down from JP¥27.25 in 3Q 2025). Revenue: JP¥1.06b (down 8.8% from 3Q 2025). Net income: JP¥147.0m (down 29% from 3Q 2025). Profit margin: 14% (down from 18% in 3Q 2025). The decrease in margin was driven by lower revenue.
お知らせ • Nov 29Medix Inc. to Report Q3, 2026 Results on Feb 10, 2026Medix Inc. announced that they will report Q3, 2026 results on Feb 10, 2026
お知らせ • Sep 04Medix Inc. to Report Q2, 2026 Results on Nov 11, 2025Medix Inc. announced that they will report Q2, 2026 results on Nov 11, 2025
お知らせ • May 31Medix Inc. to Report Q1, 2026 Results on Aug 12, 2025Medix Inc. announced that they will report Q1, 2026 results on Aug 12, 2025
お知らせ • Mar 22Medix Inc. to Report Fiscal Year 2025 Results on May 13, 2025Medix Inc. announced that they will report fiscal year 2025 results on May 13, 2025
Reported Earnings • May 19Full year 2026 earnings released: EPS: JP¥56.04 (vs JP¥106 in FY 2025)Full year 2026 results: EPS: JP¥56.04 (down from JP¥106 in FY 2025). Revenue: JP¥4.26b (up 2.3% from FY 2025). Net income: JP¥436.0m (down 46% from FY 2025). Profit margin: 10% (down from 19% in FY 2025). The decrease in margin was driven by higher expenses.
お知らせ • May 14Medix Inc., Annual General Meeting, Jun 26, 2026Medix Inc., Annual General Meeting, Jun 26, 2026.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 12 June 2026. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.0%).
分析記事 • Feb 16Why Investors Shouldn't Be Surprised By Medix Inc.'s (TSE:331A) Low P/EWith a price-to-earnings (or "P/E") ratio of 7.6x Medix Inc. ( TSE:331A ) may be sending bullish signals at the moment...
Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: JP¥19.50 (vs JP¥27.25 in 3Q 2025)Third quarter 2026 results: EPS: JP¥19.50 (down from JP¥27.25 in 3Q 2025). Revenue: JP¥1.06b (down 8.8% from 3Q 2025). Net income: JP¥147.0m (down 29% from 3Q 2025). Profit margin: 14% (down from 18% in 3Q 2025). The decrease in margin was driven by lower revenue.
お知らせ • Nov 29Medix Inc. to Report Q3, 2026 Results on Feb 10, 2026Medix Inc. announced that they will report Q3, 2026 results on Feb 10, 2026
お知らせ • Sep 16Medix Inc. (TSE:331A) announces an Equity Buyback for 600,000 shares, representing 7.47% for ¥308.4 million.Medix Inc. (TSE:331A) announces a share repurchase program. Under the program, the company will repurchase up to 600,000 shares, representing 7.47% of its issued share capital (excluding treasury stock), for a total purchase price of ¥308.4 million. The shares will be repurchased at a price of ¥514 per share. The purpose of the program is to enable flexible capital policies that respond to changes in the business environment. As of September 16, 2025, the company had 8,030,000 issued shares (excluding treasury stock) and 50,000 treasury shares.
お知らせ • Sep 05Medix Inc. (TSE:331A) agreed to acquire 76.91% stake in Star To Asia Co., Ltd from Findstar Co., Ltd., Teppei Fujiwara and Masao Liang for TWD 185 million.Medix Inc. (TSE:331A) agreed to acquire 76.91% stake in Star To Asia Co., Ltd from Findstar Co., Ltd., Teppei Fujiwara and Masao Liang for TWD 185 million on September 4, 2025. A cash consideration of TWD 144 million will be paid by Medix Inc. Medix Inc. will pay an earnout payment of TWD 41 million cash. As part of consideration, TWD 185 million is paid towards common equity of Star To Asia Co., Ltd. The transaction is subject to consummation of due diligence investigation. The expected completion of the transaction is September 30, 2025. The advisory fees is TWD 0.62 million.
お知らせ • Sep 04Medix Inc. to Report Q2, 2026 Results on Nov 11, 2025Medix Inc. announced that they will report Q2, 2026 results on Nov 11, 2025
お知らせ • May 31Medix Inc. to Report Q1, 2026 Results on Aug 12, 2025Medix Inc. announced that they will report Q1, 2026 results on Aug 12, 2025
お知らせ • May 13Medix Inc., Annual General Meeting, Jun 27, 2025Medix Inc., Annual General Meeting, Jun 27, 2025.
お知らせ • Mar 22Medix Inc. to Report Fiscal Year 2025 Results on May 13, 2025Medix Inc. announced that they will report fiscal year 2025 results on May 13, 2025
お知らせ • Mar 19Medix Inc. has completed an IPO in the amount of ¥1.84 billion.Medix Inc. has completed an IPO in the amount of ¥1.84 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 1,800,000 Price\Range: ¥800 Discount Per Security: ¥64 Security Name: Common Stock Security Type: Common Stock Securities Offered: 500,000 Price\Range: ¥800 Discount Per Security: ¥64